New physiological targets within the kidney for antihypertensive therapy

Drug Design Reviews Online

Volumn 2, Issue 2, 2005, Pages 167-178

  Evans, R G ^a   Kett, M M ^a   Shweta, A ^a   Fitzgerald, S M ^a   Denton, K M ^a   Eppel, G A ^a   Edgley, A J ^a   Anderson, W P ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Hypertension; Kidney circulation; Oxygen metabolism; Reactive oxygen species; Sympathetic nerves; Vascular hypertrophy

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ARACHIDONIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYTOCHROME P450; GANGLION BLOCKING AGENT; NATRIURETIC FACTOR; OXYGEN; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; VASODILATOR AGENT;

ANTIHYPERTENSIVE THERAPY; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; DIURETIC ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG TARGETING; FLUID BALANCE; GLOMERULUS FILTRATION; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; KIDNEY FUNCTION; KIDNEY INNERVATION; KIDNEY MEDULLA; KIDNEY METABOLISM; KIDNEY PERFUSION; KIDNEY TUBULE ABSORPTION; MAINTENANCE THERAPY; NATRIURESIS; NONHUMAN; OXIDATIVE STRESS; PHARMACODYNAMICS; PRIORITY JOURNAL; PROPHYLAXIS; REGULATORY MECHANISM; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM BALANCE; STRUCTURE ACTIVITY RELATION; VASCULAR SMOOTH MUSCLE;

EID: 23944435495     PISSN: 15672697     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567269053202651     Document Type: Review

References (89)

1. MacMahon, S.; Peto, R.; Collins, M.B.; Godwin, J.; Cutler, J.; Sorlie, P.; Abbott, R.; Neaton, J.; Dyer, A.; Stamler, J. Lancet,1990, 335, 765.
2. Burt, V.L.; Cutler, J.A.; Higgins, M.; Horan, M.J.; Labarthe, D.; Whelton, P.; Brown, C.; Roccella, E.J. Hypertension, 1995, 26, 60.
3. Rodgers, A.; MacMahon, S.; Yee, T.; Clark, T. Lancet, 1998, 352,1801.
4. Cuspidi, C.; Macca, G.; Sampieri, L.; Michev, L.; Salerno, M.; Fusi, V.; Severgnini, B.; Meani, S.; Magrini, F.; Zanchetti, A. J. Hypertens., 2001, 19, 2063.
5. Guyton, A.C.; Coleman, T.G.; Cowley, A.W. Jr.; Scheel, K.W.; Manning, R.D.; Norman, R.A. Am. J. Med., 1972, 52, 584.
6. Guyton, A.C. Am. J. Physiol., 1990, 259, R865.
7. Cowley, A.W. Jr. Physiol. Rev., 1992, 72, 231.
8. Weinberger, M.H.; Fineberg, N.S.; Fineberg, S.E.; Weinberger, M. Hypertension, 2001, 37, 429.
9. Rettig, R.; Schmitt, B.; Peilzl, B.; Speck, T. J. Hypertens., 1993,11, 883.
10. Man in't Veld, A.J.; van den Meiracker, A.H. In: Hypertension: Pathophysiology, Diagnosis, and Management. (2nd ed.), Laragh, Brenner, Eds. Raven Press Ltd: New York 1995, Vol.2, pp. 2753-2763.
11. Freis, E.D. In: Hypertension: Pathophysiology, Diagnosis and Management (2nd ed.), Laragh, Brenner, Eds. Raven Press Ltd: New York 1995, Vol.2, pp. 2741-2751.
12. Unwin, R.J.; Ligueros, M.; Shakelton, C.; Wilcox, C.S. In: Hypertension: Pathophysiology, Diagnosis and Management (2nd ed.), Laragh, Brenner, Eds. Raven Press Ltd: New York 1995, Vol.2, pp. 2785-2799.
13. Hall, J.E.; Brands, M.W. In: The Renin-Angiotensin System, JIS Robertson, Eds. Gower Medical Publishing: London 1993, Vol.1, pp. 26.21-26.43.
14. Buhler, F.R. In: Hypertension: Pathophysiology, Diagnosis, and Management (2nd ed.), Laragh, Brenner, Eds. Raven Press Ltd: New York 1995, Vol.2, pp. 2801-2814.
15. DiBona, G.F.; Kopp, U.C. Physiol. Rev., 1997, 77, 75.
16. Pritchard, B.N.C.; Cruickshank, J.M. In: Hypertension: Pathophysiology, Diagnosis, and Management (2nd ed.), Laragh, Brenner, Eds. Raven Press Ltd: New York 1995, Vol.2, pp. 2827-2859.
17. Evans, R.G. Clin. Exp. Pharmacol. Physiol., 1996, 23, 845.
18. Laverman, G.D.; Remuzzi, G.; Ruggenenti, P. J. Am. Soc. Nephrol., 2004, 15, S64.
19. Berl, T. J. Am. Soc. Nephrol., 2004, 15, S71.
20. Folkow, B. Blood Press., 1994, 3, 212.
21. Bretzel, R.G. J. Hypertens., 1997, 15(Suppl 2), S83.
22. Cowley, A.W. Jr. Am. J. Physiol, 1997, 273, R1.
23. Cowley, A.W. Jr.; Mori, T.; Mattson, D.; Zou, A.-P. Am. J. Physiol, 2003, 284, R1355.
24. Mattson, D.L. Am. J. Physiol, 2003, 284, R13.
25. Correia, A.G.; Madden, A.C.; Bergstrom, G.; Evans, R.G. Hypertension, 2000, 35, 965.
26. Bergström, G.; Evans, R.G. Acta. Physiol. Scand., 2004, 181, 475.
27. McDonough, A.A.; Leong, P.K.; Yang, L.E. Ann. N. Y. Acad. Sci., 2003, 986, 669.
28. Evans, R.G.; Eppel, G.A.; Anderson, W.P.; Denton, K.M. J. Hypertens., 2004, 22, 1439.
29. Bergström, G.; Evans, R.G. In: The Renal Circulation, Anderson, Evans, Stevenson, Eds. JAI Press Inc: Stamford, Connecticut 2000, Vol.9, pp. 235-254.
30. Eppel, G.A.; Malpas, S.C.; Denton, K.M.; Evans, R.G. Clin. Exp. Pharmacol. Physiol., 2004, 31, 387.
31. Duke, L.M.; Eppel, G.A.; Widdop, R.E.; Evans, R.G. Hypertension, 2003, 42, 200.
32. Eppel, G.A.; Lee, L.L.; Evans, R.G. Auton. Neurosci., 2004, 112,15.
33. Dukacz, S.A.W.; Feng, M.-G.; Yang, L.-F.; R.M.K.W., L.; R.L., K. Am. J. Physiol, 2001, 280, R1076.
34. Evans, R.G.; Madden, A.C.; Oliver, J.J.; Lewis, T.V. J. Hypertens., 2001, 19, 1789.
35. Gullans, S.R.; Herbert, S.C. In: The Kidney, Brenner, Eds. WB Saunders Inc: Philadelphia 2000.
36. Brezis, M.; Agmon, Y.; Epstein, F.H. Am. J. Physiol, 1994, 267,F1059.
37. Magyar, C.E.; Zhang, Y.; Holstein-Rathlou, N.-H.; McDonough, A.A. J. Am. Soc. Nephrol., 2001, 12, 2231.
38. Brazy, P.C.; PE, K. Am. J. Physiol, 1989, 257, F818.
39. Garg, L.C.; Narang, N.; McArdle, S. Am. J. Physiol, 1985, 249, F863.
40. Welch, W.J.; Baumgartl, H.; Lubbers, D.; Wilcox, C.S. Kidney Int.,2001, 59, 230.
41. Koivisto, A.; Pittner, J.; Froelich, M.; Persson, A.E.G. Kidney Int.,1999, 55, 2368.
42. Laycock, S.K.; Vogel, T.; Forfia, P.R.; Tuzman, J.; Xu, X.; Ochoa, M.; Thompson, C.I.; Nasjletti, A.; Hintze, T.H. Circ. Res., 1998,82, 1263.
43. Vaziri, N.D. Curr. Opin. Nephrol. Hypertens., 2004, 13, 93.
44. Evans, R.G.; Fitzgerald, S.M. Curr. Opin. Nephrol. Hypertens.,2005, in press.
45. Griendling, K.K.; FitzGerald, G.A. Circulation, 2003, 108, 1912.
46. Lassegue, B.; Clempus, R.E. Am. J. Physiol, 2003, 285, R277.
47. Reckelhoff, J.F.; Romero, J.C. Am. J. Physiol, 2003, 284, R893.
48. Griendling, K.K.; FitzGerald, G.A. Circulation, 2003, 108, 2034.
49. Endemann, D.H.; Schiffrin, E.L. Curr. Hypertens. Rep., 2004, 6,85.
50. Chen, Y.-F.; Cowley, A.W. Jr.; Zou, A.-P. Am. J. Physiol, 2003,285, R827.
51. Makino, A.; Skelton, M.M.; Zou, A.-P.; Cowley, A.W.Jr. Hypertension, 2003, 42, 25.
52. Imig, J.D. Am. J. Physiol, 2000, 279, F965.
53. Roman, R.J. Physiol. Rev., 2002, 82, 131.
54. Dos Santos, E.A.; Dahly-Vernon, A.J.; Hoagland, K.M.; Roman, R.J. Am. J. Physiol., 2004, 287, R58.
55. Fleming, I. Pharmacol. Res., 2004, 49, 525.
56. Busse, R.; Edwards, G.; Feletou, M.; Fleming, I.; Vanhoutte, P.M.; Weston, A.H. Trends Pharmacol. Sci., 2002, 23, 374.
57. Feletou, M.; Vanhoutte, P.M. Pharmacol. Res., 2004, 49, 565.
58. Rajapakse, N.W.; Roman, R.J.; Falck, J.R.; Oliver, J.J.; Evans, R.G. Am. J. Physiol., 2004, 287, R181.
59. Gauthier, K.M.; Falck, J.R.; Reddy, L.L.; Campbell, W.B. Pharmacol. Res., 2004, 49, 515.
60. Zhao, X.; Yamamoto, T.; Newman, J.W.; Kim, I.-H.; Watanabe, T.; Hammock, B.D.; Stewart, J.; Pollock, J.S.; Pollock, D.M.; Imig, J.D. J. Am. Soc. Nephrol., 2004, 15, 1244.
61. Morrison, S.F. Am. J. Physiol., 2001, 281, R683.
62. Luff, S.E.; Hengstberger, S.G.; McLachlan, E.M.; Anderson, W.P. J. Neurocytol., 1991, 20, 781.
63. DiBona, G.F.; Sawin, L.L.; Jones, S.Y. Am. J. Physiol, 1996, 271,R84.
64. Furness, J.B.; Morris, J.L.; Gibbins, I.L.; Costa, M. Annu. Rev. Pharmacol. Toxicol., 1989, 29, 289.
65. Burnstock, G. Curr. Opin. Pharmacol., 2004, 4, 47.
66. Denton, K.M.; Shweta, A.; Flower, R.L.; Anderson, W.P. Am. J. Physiol., 2004, doi:10.1152/ajpregu.00202.2004.
67. Karavanov, A.; Sainio, K.; Palgi, J.; Saarma, M.; Saxen, L.; Sariola, H. Proc. Natl. Acad. Sci. USA, 1995, 92, 11279.
68. Luff, S.E.; Hengstberger, S.G.; McLachlan, E.M.; Anderson, W.P. J. Auton. Nerv. Syst., 1992, 40, 239.
69. Denton, K.M.; Shweta, A.; Anderson, W.P. J. Am. Soc. Nephrol.,2002, 13, 27.
70. Esler, M. J. Cardiovasc. Pharmacol., 1995, 26, S24.
71. Orth, S.R.; Amann, K.; Strojek, K.; Ritz, E. Nephrol. Dial. Transplant., 2001, 16 Suppl 1, 67.
72. Awazu, M.; Ichikawa, I. Semin. Nephrol., 1994, 14, 401.
73. Parkington, H.C.; Dodd, J.; Luff, S.E.; Worthy, K.; Coleman, H.A.; Tare, M.; Anderson, W.P.; Edgley, A.J. Hypertension, 2004, 43,643.
74. Brenner, B.M.; Garcia, D.L.; Anderson, S. Am. J. Hypertens., 1988,1, 335.
75. Keller, G.; Zimmer, G.; Mall, G.; Ritz, E.; Amann, K. N. Eng. J. Med., 2003, 348, 101.
76. Kett, M.M.; Bertram, J.F. Curr. Hypertens. Rep., 2004, 6, 133.
77. Imai, E.; Ito, T. Pediat. Nephrol., 2002, 17, 790.
78. Lelievre-Pegorier, M.; Vilar, J.; Ferrier, M.L.; Moreau, E.; Freund, N.; Gilbert, T.; Merlet-Benichou, C. Kidney Int., 1998, 54, 1455.
79. Anderson, W.P.; Kett, M.M.; Stevenson, K.M.; Edgley, A.J.; Denton, K.M.; Fitzgerald, S.M. Hypertension, 2000, 36, 648.
80. Kett, M.M.; Alcorn, D.; Bertram, J.F.; Anderson, W.P. Hypertension, 1995, 25, 335.
81. Korner, P.I.; Angus, J.A. J. Vasc. Res., 1992, 29, 293.
82. Kett, M.M.; Bergstrom, G.; Alcorn, D.; Bertram, J.F.; Anderson, W.P. J. Hypertens., 2001, 19, 1505.
83. Wolf, G.; Wenzel, U.O. Hypertension, 2004, 43, 693.
84. Touyz, R.M. Braz. J. Med. Biol. Res., 2004, 37, 1263.
85. Kett, M.M.; Anderson, W.P.; Bertram, J.F.; Alcorn, D. Clin. Exp. Pharmacol. Physiol., 1996, Suppl. 3, S132.
86. Anderson, W.P.; Kett, M.M.; Alcorn, D.; Bertram, J.F. Clin. Exp. Hypertens. A, 1997, 19, 965.
87. Smeda, J.S.; Lee, R.M.K.W.; Forrest, J.B. Circ. Res., 1988, 63,534.
88. Austin, C.P. Annu. Rev. Med., 2004, 55, 1.
89. Guyton, A.C.; Hall, J.E. Textbook of Medical Physiology. W.B. Saunders: Philadelphia, 2000.